These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 37190751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
    Maseda E, Grau S, Luque S, Castillo-Mafla MP, Suárez-de-la-Rica A, Montero-Feijoo A, Salgado P, Gimenez MJ, García-Bernedo CA, Gilsanz F, Roberts JA.
    Crit Care; 2018 Apr 15; 22(1):94. PubMed ID: 29655372
    [Abstract] [Full Text] [Related]

  • 4. Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients.
    Martial LC, Ter Heine R, Schouten JA, Hunfeld NG, van Leeuwen HJ, Verweij PE, de Lange DW, Pickkers P, Brüggemann RJ.
    Clin Pharmacokinet; 2017 Oct 15; 56(10):1197-1206. PubMed ID: 28144840
    [Abstract] [Full Text] [Related]

  • 5. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
    Mehta PA, Vinks AA, Filipovich A, Bleesing J, Jodele S, Jordan MB, Marsh R, Tarin R, Edwards S, Fearing D, Lawrence J, Davies SM.
    Biol Blood Marrow Transplant; 2010 Oct 15; 16(10):1458-62. PubMed ID: 20546908
    [Abstract] [Full Text] [Related]

  • 6. Assessment of micafungin loading dosage regimens against Candida spp. in ICU patients by Monte Carlo simulations.
    Lu X, Xu G, Chen L, Fan J, Li M, Zhu L.
    Eur J Clin Pharmacol; 2020 May 15; 76(5):695-702. PubMed ID: 32047965
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
    Pérez-Pitarch A, Ferriols-Lisart R, Aguilar G, Ezquer-Garín C, Belda FJ, Guglieri-López B.
    Int J Antimicrob Agents; 2018 Jan 15; 51(1):115-121. PubMed ID: 28666752
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study.
    Chandra S, Fukuda T, Mizuno K, Davies SM, Teusink-Cross A, Tarin R, Marsh RA, Vinks AA, Mehta PA.
    J Antimicrob Chemother; 2018 Jun 01; 73(6):1651-1658. PubMed ID: 29481593
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients.
    Scott LJ.
    Paediatr Drugs; 2017 Feb 01; 19(1):81-90. PubMed ID: 28083856
    [Abstract] [Full Text] [Related]

  • 20. Optimal dosing regimen of caspofungin in adolescents with allogeneic haematopoietic stem cell transplantation.
    Du B, Zhang W, Wang Y, Wu YE, Zhang YH, van den Anker J, Hao GX, Zhao W.
    J Antimicrob Chemother; 2024 Oct 01; 79(10):2678-2687. PubMed ID: 39119901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.